Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Coherus Oncology, Inc.
Wake Forest University Health Sciences
PT. Prodia Stem Cell Indonesia
Poseida Therapeutics, Inc.
Sun Yat-sen University
Sun Yat-sen University
SystImmune Inc.
University of California, San Diego
Sun Yat-sen University
Sun Yat-sen University
University of Nebraska
Takeda
Novartis
Guangxi Medical University
M.D. Anderson Cancer Center
Incyte Corporation
Stanford University
National University Hospital, Singapore
University of Colorado, Denver
Travera Inc
The First Affiliated Hospital of Xiamen University
National Cancer Centre, Singapore
Marengo Therapeutics, Inc.
The First Affiliated Hospital of Xiamen University
Indonesia University
National Cancer Centre, Singapore
Sun Yat-sen University
Maria Sklodowska-Curie National Research Institute of Oncology
University of California, San Francisco
Konya Beyhekim Training and Research Hospital
Shanghai JMT-Bio Inc.
BeiGene
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
Sun Yat-sen University
National University Hospital, Singapore
University of Washington
National University Hospital, Singapore
Atara Biotherapeutics
King Saud University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Zhejiang Cancer Hospital
University of California, San Diego
Zhujiang Hospital
The Christie NHS Foundation Trust
National Cancer Centre, Singapore
German Society for Pediatric Oncology and Hematology GPOH gGmbH